Implantable cardioverter‐defibrillator in patients with spontaneous coronary artery dissection presenting with sudden cardiac arrest. (15th August 2021)

• Record Type: Journal Article
• Authors: Garg, Jalaj; Shah, Kuldeep; Shah, Siddharth; Turagam, Mohit K.; Natale, Andrea; Lakkireddy, Dhanunjaya
• Is Part Of: Journal of cardiovascular electrophysiology. Volume 32:Number 9(2021)
• Page Start: 2595
• Page End: 2600
• Publication Date: 2021-08-15
• Subjects: clinical: electrophysiology—cardiac arrest/sudden death -- implantable cardioverter‐defibrillator -- spontaneous coronary artery dissection; Blood vessels -- Physiology -- Periodicals; Electrophysiology -- Periodicals; Heart -- Physiology -- Periodicals; 612.1
• DOI: 10.1111/jce.15201
• Languages: English
• ISSNs: 1045-3873

Abstract

Abstract: Introduction: The role of secondary prevention implantable cardioverter‐defibrillator (ICD) remains uncertain in spontaneous coronary artery dissection (SCAD) patients presenting with sudden cardiac arrest (SCA). Methods: We aimed at assessing the outcomes following SCA and the role of ICD therapy in SCAD. The meta‐analysis was performed using a meta‐package for R version 4.0/RStudio version 1.2 and the Freeman–Tukey double arcsine method to establish the variance of raw proportions. Outcomes measured included—(1) incidence of ICD implantation, (2) appropriate and inappropriate ICD therapy, (3) recurrence of SCAD and SCA, and (4) all‐cause mortality. Results: Five studies, including 139 SCAD patients with SCA met study inclusion criteria. The mean age was 47.3 ± 12.8 years, mean left ventricular ejection fraction 43.8 ± 10.8%, 88% were female (12% had pregnancy‐associated SCAD. Causes of SCA included ventricular arrhythmia (97.9%, n = 136) and pulseless electrical activity (2.1%, n = 3). Overall, 20% patients (95% confidence interval [CI]: 7.1%–36.6%, I 2 = 68%) received ICD, of which 1.2% (95% CI: 0%–15.8%, I 2 = 0%) and 1% (95% CI: 0%–15.3%, I 2 = 0%) patients received appropriate and inappropriate ICD therapies, respectively, during follow‐up period (4.1 ± 3.3 years). Incidence of recurrent SCAD was 9% (95% CI: 2.85%–17.5%, I 2 = 25%), and recurrent SCA was 3.85% patients (95% CI: 0.65%–8.7%, I 2 = 0%; one patient with appropriate ICD therapy). The pooled incidence of all‐cause mortality was 6.2% (95% CI: 0.6%–15.1%, I 2 = 44%). Conclusion: Although ICD therapy is beneficial in patients (all comers) presenting with cardiac arrest; the risk‐benefit ratio of secondary prevention ICD arrest remains unclear. Patient‐centered shared decision‐making and risk‐benefit ratio assessment should be performed before consideration for ICD implantation.